Education
About Us
Working with TipRanks
Follow Us
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP)
LSE:BXP
BXP Stock Chart & Stats
44.50p
0.00p(0.00%)
At close: 4:00 PM EST
44.50p
0.00p(0.00%)
Day’s Range― - ―
52-Week Range31.55p - 52.33p
Previous CloseN/A
Volume9.88K
Average Volume (3M)23.54K
Market Cap
49.03B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)4.6
Beta0.30
Next Earnings
Nov 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.81%
Share Statistics
EPS (TTM)N/A
Shares Outstanding446,112,100
10 Day Avg. Volume17,188
30 Day Avg. Volume23,537
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.46
Revenue Forecast (FY)22.99B
Beximco Pharmaceuticals Limited Sponsored GDR RegS News
BXP FAQ
What was Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price range in the past 12 months?
Beximco Pharmaceuticals Limited Sponsored GDR RegS lowest share price was 31.55p and its highest was 52.33p in the past 12 months.
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s market cap?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s market cap is 49.03B.
When is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date is Nov 06, 2025 which is 42 days ago.
How were Beximco Pharmaceuticals Limited Sponsored GDR RegS’s earnings last quarter?
Currently, no data Available
Is Beximco Pharmaceuticals Limited Sponsored GDR RegS overvalued?
According to Wall Street analysts Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price is currently Overvalued.
Does Beximco Pharmaceuticals Limited Sponsored GDR RegS pay dividends?
Beximco Pharmaceuticals Limited Sponsored GDR RegS pays a Annually dividend of 3.349p which represents an annual dividend yield of 4.81%. See more information on Beximco Pharmaceuticals Limited Sponsored GDR RegS dividends here
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beximco Pharmaceuticals Limited Sponsored GDR RegS have?
Beximco Pharmaceuticals Limited Sponsored GDR RegS has 446,112,100 shares outstanding.
What happened to Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Beximco Pharmaceuticals Limited Sponsored GDR RegS?
Currently, no hedge funds are holding shares in GB:BXP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beximco Pharmaceuticals Limited Sponsored GDR RegS Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.